Sequential Design of Activatable Photosensitizers for Ablation of Glioma Cells in Brain Cancer Tissues

ABSTRACT Photodynamic therapy (PDT) is a promising strategy to eradicate residual glioma cells in brain cancer patients; however, current photosensitizers (PS) show limitations on selective accumulation and controlled activation in glioma cells. In this work, we present the design, synthesis, and characterization of activatable PSs for selective PDT of glioma cells in mouse and human brain tissues. First, we designed and characterized a broad collection of photosensitive metabolite conjugates, from which we prepared Gal‐SeNBD‐oleamide as a β‐galactosidase‐responsive PS with efficient uptake in patient‐derived glioma cells and selectivity over immune cells. Furthermore, we optimized a whole‐tissue illumination strategy using Gal‐SeNBD‐oleamide in mouse brain slices, which led to efficient ablation of cancer cells with minimal damage to surrounding regions. Finally, the proof‐of‐concept application of Gal‐SeNBD‐oleamide directly in tissues from brain cancer patients supports its translational potential for PDT of glioblastoma.

Authors

Institutions

Publication Details

Journal
Angewandte Chemie International Edition
Published
2026-09-30
DOI
https://doi.org/10.1002/anie.8453410
Primary Topic
Photodynamic Therapy Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Sequential Design of Activatable Photosensitizers for Ablation of Glioma Cells in Brain Cancer Tissues

Deborah Seah, Neza Alfazema, Andrew D M Green, Fabio De Moliner et al.
Angewandte Chemie International Edition
Photodynamic Therapy Research Studies
article

Sequential Design of Activatable Photosensitizers for Ablation of Glioma Cells in Brain Cancer Tissues

Deborah Seah, Neza Alfazema, Andrew D M Green, Fabio De Moliner, Marc Vendrell, Sam Benson, Steven M. Pollard, Utsa Karmakar, Michael G. Tanner, Paul Martin Brennan, Eleni Nestoros, Sonja Vermeren, Thibaud Aymoz-Bressot, Alsadeg Bilal, Zhiming Cheng, Justyna Cholewa‐Waclaw, Gillian Morrison, Paula Lusarreta, Clarissa Lim
article en

Abstract

ABSTRACT Photodynamic therapy (PDT) is a promising strategy to eradicate residual glioma cells in brain cancer patients; however, current photosensitizers (PS) show limitations on selective accumulation and controlled activation in glioma cells. In this work, we present the design, synthesis, and characterization of activatable PSs for selective PDT of glioma cells in mouse and human brain tissues. First, we designed and characterized a broad collection of photosensitive metabolite conjugates, from which we prepared Gal‐SeNBD‐oleamide as a β‐galactosidase‐responsive PS with efficient uptake in patient‐derived glioma cells and selectivity over immune cells. Furthermore, we optimized a whole‐tissue illumination strategy using Gal‐SeNBD‐oleamide in mouse brain slices, which led to efficient ablation of cancer cells with minimal damage to surrounding regions. Finally, the proof‐of‐concept application of Gal‐SeNBD‐oleamide directly in tissues from brain cancer patients supports its translational potential for PDT of glioblastoma.

Angewandte Chemie International Edition
Edinburgh Cancer Research (GB), Heriot-Watt University (GB), MRC Centre for Regenerative Medicine (GB), Centre for Inflammation Research (GB), University of Edinburgh (GB)
Openalex Percentile: Top 12%
Photodynamic Therapy Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.